Disease X Act of 2023
3/12/2024, 9:21 PMSummary of Bill S 2093
Bill 118 s 2093, also known as the Disease X Act of 2023, is a piece of legislation introduced in the US Congress with the aim of addressing the potential threat of unknown or emerging infectious diseases, often referred to as "Disease X." The bill seeks to establish a comprehensive framework for detecting, monitoring, and responding to such diseases in order to protect public health and national security.Key provisions of the Disease X Act of 2023 include the creation of a task force comprised of experts in infectious diseases, public health, and emergency response to develop strategies for early detection and containment of Disease X outbreaks. The bill also calls for increased funding for research and development of vaccines, treatments, and diagnostic tools for unknown or emerging diseases.
Additionally, the legislation emphasizes the importance of international cooperation and information sharing in order to effectively combat Disease X on a global scale. It also mandates regular reporting to Congress on the status of Disease X preparedness and response efforts. Overall, the Disease X Act of 2023 aims to strengthen the nation's ability to respond to the threat of unknown or emerging infectious diseases and to ensure that the US is better prepared to protect the health and safety of its citizens in the face of future outbreaks.
Congressional Summary of S 2093
Disease X Act of 2023
This bill expands the priorities of the Biomedical Advanced Research and Development Authority (BARDA) to specifically include viral threats that have the potential to cause a pandemic.
In particular, the bill expands the scope of innovation grants and contracts that may be awarded by BARDA to specifically include those that support research and development of certain manufacturing technology for medical countermeasures against viruses, including respiratory viruses, with pandemic potential. It also expands BARDA's authorized strategic initiatives to include advanced research, development, and procurement of countermeasures and products to address viruses with pandemic potential.
Read the Full Bill
Current Status of Bill S 2093
Bill S 2093 is currently in the status of Bill Introduced since June 21, 2023. Bill S 2093 was introduced during Congress 118 and was introduced to the Senate on June 21, 2023. Bill S 2093's most recent activity was Read twice and referred to the Committee on Health, Education, Labor, and Pensions. as of June 21, 2023Bipartisan Support of Bill S 2093
Total Number of Sponsors
1Democrat Sponsors
1Republican Sponsors
0Unaffiliated Sponsors
0Total Number of Cosponsors
2Democrat Cosponsors
0Republican Cosponsors
2Unaffiliated Cosponsors
0Policy Area and Potential Impact of Bill S 2093
Primary Policy Focus
HealthPotential Impact Areas
Advanced technology and technological innovationsInfectious and parasitic diseasesMedical researchResearch administration and fundingResearch and developmentAlternate Title(s) of Bill S 2093
Disease X Act of 2023Disease X Act of 2023A bill to establish a program at BARDA for developing medical countermeasures for viral threats with pandemic potential.Comments
Most relevant
Sponsors and Cosponsors of S 2093
Latest Bills
Consensual Donation and Research Integrity Act of 2025
Bill S 1270April 15, 2025
Youth Mental Health Research Act
Bill S 1266April 15, 2025
Feral Swine Eradication Act
Bill S 1207April 15, 2025
Defending America’s Future Elections Act
Bill S 1240April 15, 2025
Trade Review Act of 2025
Bill S 1272April 15, 2025
IVF for Military Families Act
Bill S 1231April 15, 2025
Fishing Industry Credit Enhancement Act of 2025
Bill S 1217April 15, 2025
Safety Starts at the Top Act of 2025
Bill S 1268April 15, 2025
Protecting American Households From Rising Energy Costs Act of 2025
Bill S 1274April 15, 2025
SAFETY Act of 2025
Bill S 1230April 15, 2025
Disease X Act of 2023
Bill HR 3832February 5, 2024